ClinicalTrials.govpublic full text
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
coronary microvascular dysfunction, cardiotoxicity, breast cancer, lung cancer (nsclc), cancer therapy related cardiotoxicity, immune checkpoint inhibitor therapy, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893644
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.